MedTrace Logo

Study on Plasmablastic Lymphoma Patients

NCT06781359 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-12-02

No results posted yet for this study

Summary

This is an observational, multicenter, international and retrospective study, that aims to collect data on clinical and pathological characteristics, treatment regimens, outcome, and prognostic factors (clinical, biomarkers and/or radio-metabolic) in patients affected by PBL.

Conditions

  • Plasmablastic Lymphoma

Sponsors & Collaborators

  • AIL Roma - Italia

    collaborator UNKNOWN

  • AIL Cuneo - Italia

    collaborator UNKNOWN

  • Fondazione Italiana Linfomi - ETS

    lead OTHER

Principal Investigators

  • Alessia Castellino, MD · UO Ematologia, AO Santa Croce e Carle, Cuneo - Italy

  • Emanuele Ravano, MD · UO Ematologia, Niguarda Grande Ospedale Metropolitano, Milano - Italy.

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-14
Primary Completion
2028-02-01
Completion
2028-02-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06781359 on ClinicalTrials.gov